• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一系列双齿 ONS 给体配体的非氧化 V 配合物:溶液稳定性、化学转化、蛋白质相互作用和抗增殖活性。

A Series of Non-Oxido V Complexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity.

机构信息

Department of Chemistry, National Institute of Technology, Rourkela 769008, Odisha, India.

Institute of Chemical Research of Catalonia (ICIQ), The Barcelona Institute of Science and Technology, Tarragona 43007, Spain.

出版信息

Inorg Chem. 2023 May 22;62(20):7932-7953. doi: 10.1021/acs.inorgchem.3c00753. Epub 2023 May 8.

DOI:10.1021/acs.inorgchem.3c00753
PMID:37154533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10367067/
Abstract

A series of mononuclear non-oxido vanadium(IV) complexes, [V(L)] (), featuring tridentate bi-negative ONS chelating S-alkyl/aryl-substituted dithiocarbazate ligands HL, are reported. All the synthesized non-oxido V compounds are characterized by elemental analysis, spectroscopy (IR, UV-vis, and EPR), ESI-MS, as well as electrochemical techniques (cyclic voltammetry). Single-crystal X-ray diffraction studies of - reveal that the mononuclear non-oxido V complexes show distorted octahedral ( and ) or trigonal prismatic () arrangement around the non-oxido V center. EPR and DFT data indicate the coexistence of and isomers in solution, and ESI-MS results suggest a partial oxidation of [V(L)] to [V(L)] and [VO(L)]; therefore, all these three complexes are plausible active species. Complexes - interact with bovine serum albumin (BSA) with a moderate binding affinity, and docking calculations reveal non-covalent interactions with different regions of BSA, particularly with Tyr, Lys, Arg, and Thr residues. cytotoxic activity of all complexes is assayed against the HT-29 (colon cancer) and HeLa (cervical cancer) cells and compared with the NIH-3T3 (mouse embryonic fibroblast) normal cell line by MTT assay and DAPI staining. The results suggest that complexes - are cytotoxic in nature and induce cell death in the cancer cell lines by apoptosis and that a mixture of V, V, and VO species could be responsible for the biological activity.

摘要

一系列单核非氧化型钒(IV)配合物,V(L),具有三齿双负 ONS 螯合 S-烷基/芳基取代的二硫代氨基甲酸盐配体 HL。所有合成的非氧化钒化合物均通过元素分析、光谱学(IR、UV-vis 和 EPR)、ESI-MS 以及电化学技术(循环伏安法)进行了表征。-的单晶 X 射线衍射研究表明,单核非氧化钒配合物在非氧化钒中心周围呈现扭曲的八面体(和)或三角棱柱()排列。EPR 和 DFT 数据表明,在溶液中存在和异构体的共存,ESI-MS 结果表明[V(L)]部分氧化为[V(L)]和[VO(L)];因此,所有这三种配合物都是合理的活性物质。配合物-与牛血清白蛋白(BSA)具有中等的结合亲和力,对接计算揭示了与 BSA 不同区域的非共价相互作用,特别是与 Tyr、Lys、Arg 和 Thr 残基。所有配合物的细胞毒性活性均通过 MTT 测定和 DAPI 染色法在 HT-29(结肠癌)和 HeLa(宫颈癌)细胞上进行了测定,并与 NIH-3T3(小鼠胚胎成纤维细胞)正常细胞系进行了比较。结果表明,配合物-具有细胞毒性,通过凋亡诱导癌细胞系中的细胞死亡,并且 V、V 和 VO 混合物种可能是生物活性的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/0ed759371e12/ic3c00753_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/ab14b7058cb8/ic3c00753_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/b1915ff1d129/ic3c00753_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/840ab1437f81/ic3c00753_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/71f224dae4e0/ic3c00753_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/a8a76f3c104e/ic3c00753_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/32dd0d108805/ic3c00753_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/780a53910ffb/ic3c00753_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/12d0c7fe945b/ic3c00753_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/62d8d7e2fe8c/ic3c00753_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/3907c613b861/ic3c00753_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/c9ae8d3f16e3/ic3c00753_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/89592b4a79f0/ic3c00753_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/f87acf401afa/ic3c00753_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/7376a7dfd381/ic3c00753_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/c4359cce9602/ic3c00753_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/0ed759371e12/ic3c00753_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/ab14b7058cb8/ic3c00753_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/b1915ff1d129/ic3c00753_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/840ab1437f81/ic3c00753_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/71f224dae4e0/ic3c00753_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/a8a76f3c104e/ic3c00753_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/32dd0d108805/ic3c00753_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/780a53910ffb/ic3c00753_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/12d0c7fe945b/ic3c00753_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/62d8d7e2fe8c/ic3c00753_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/3907c613b861/ic3c00753_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/c9ae8d3f16e3/ic3c00753_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/89592b4a79f0/ic3c00753_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/f87acf401afa/ic3c00753_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/7376a7dfd381/ic3c00753_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/c4359cce9602/ic3c00753_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/078d/10367067/0ed759371e12/ic3c00753_0016.jpg

相似文献

1
A Series of Non-Oxido V Complexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity.一系列双齿 ONS 给体配体的非氧化 V 配合物:溶液稳定性、化学转化、蛋白质相互作用和抗增殖活性。
Inorg Chem. 2023 May 22;62(20):7932-7953. doi: 10.1021/acs.inorgchem.3c00753. Epub 2023 May 8.
2
Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium(V) salan complexes: Exploring the solution behavior of monoalkoxido-bound oxido-vanadium(V) complex.单体和二聚氧代钒(V)沙兰配合物的蛋白结合和细胞毒性活性:探索单烷氧基结合的氧代钒(V)配合物的溶液行为。
J Inorg Biochem. 2021 Nov;224:111582. doi: 10.1016/j.jinorgbio.2021.111582. Epub 2021 Aug 17.
3
Evaluation of DNA/BSA interaction and in vitro cell cytotoxicity of μ-oxido bridged divanadium(V) complexes containing ONO donor ligands.评价含 ONO 供体配体的 μ-氧桥连二价钒(V)配合物与 DNA/BSA 的相互作用和体外细胞毒性。
J Inorg Biochem. 2022 Aug;233:111852. doi: 10.1016/j.jinorgbio.2022.111852. Epub 2022 May 10.
4
New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity.新型混合配体氧化钒(IV)配合物:溶液行为、蛋白相互作用和细胞毒性。
J Inorg Biochem. 2022 Aug;233:111853. doi: 10.1016/j.jinorgbio.2022.111853. Epub 2022 May 10.
5
Chemistry of Monomeric and Dinuclear Non-Oxido Vanadium(IV) and Oxidovanadium(V) Aroylazine Complexes: Exploring Solution Behavior.单核和双核非氧化态钒(IV)及氧化钒(V)芳酰肼配合物的化学性质:溶液行为研究
Inorg Chem. 2016 Feb 1;55(3):1165-82. doi: 10.1021/acs.inorgchem.5b02346. Epub 2016 Jan 20.
6
Dithiocarbazate based oxidomethoxidovanadium(V) and mixed-ligand oxidovanadium(IV) complexes: Study of solution behavior, DNA binding, and anticancer activity.基于二硫代卡巴腙的氧化亚甲基氧钒(V)和混合配体氧钒(IV)配合物:溶液行为、DNA 结合和抗癌活性研究。
J Inorg Biochem. 2022 Aug;233:111844. doi: 10.1016/j.jinorgbio.2022.111844. Epub 2022 Apr 26.
7
New V, VO, VO, and VO Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity.新型 V、VO、VO2 和 VO3 体系:探索它们在溶液、蛋白质相互作用和细胞毒性方面的相互转化。
Inorg Chem. 2020 Oct 5;59(19):14042-14057. doi: 10.1021/acs.inorgchem.0c01837. Epub 2020 Sep 11.
8
Nonoxido Vanadium(IV) Compounds Involving Dithiocarbazate-Based Tridentate ONS Ligands: Synthesis, Electronic and Molecular Structure, Spectroscopic and Redox Properties.含二硫代氨基甲酸盐基三齿ONS配体的钒(IV)非氧化物化合物:合成、电子与分子结构、光谱及氧化还原性质
Inorg Chem. 2015 Jul 6;54(13):6203-15. doi: 10.1021/acs.inorgchem.5b00359. Epub 2015 Jun 10.
9
Anionic Dinuclear Oxidovanadium(IV) Complexes with Azo Functionalized Tridentate Ligands and μ-Ethoxido Bridge Leading to an Unsymmetric Twisted Arrangement: Synthesis, X-ray Structure, Magnetic Properties, and Cytotoxicity.含偶氮功能化三齿配体和 μ-乙氧基桥的阴离子双核氧化钒(IV)配合物,导致不对称扭曲排列:合成、X 射线结构、磁性和细胞毒性。
Inorg Chem. 2018 May 21;57(10):5767-5781. doi: 10.1021/acs.inorgchem.8b00035. Epub 2018 May 9.
10
Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.具有 [V(IV)O](2+) 和 [V(V)O(2)](+) 核的钒配合物与双核双基四齿配体:合成、表征、催化和抗阿米巴活性。
Dalton Trans. 2010 Feb 7;39(5):1345-60. doi: 10.1039/b915752b. Epub 2009 Dec 1.

本文引用的文献

1
Ruthenium(II)-Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria-Targeted Apoptotic Cell Death.二硫代氨基甲酸盐钌(II)作为抗癌剂:合成、溶液行为及线粒体靶向性凋亡细胞死亡
Chemistry. 2023 Mar 28;29(18):e202202694. doi: 10.1002/chem.202202694. Epub 2023 Feb 24.
2
New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity.新型混合配体氧化钒(IV)配合物:溶液行为、蛋白相互作用和细胞毒性。
J Inorg Biochem. 2022 Aug;233:111853. doi: 10.1016/j.jinorgbio.2022.111853. Epub 2022 May 10.
3
Evaluation of DNA/BSA interaction and in vitro cell cytotoxicity of μ-oxido bridged divanadium(V) complexes containing ONO donor ligands.
评价含 ONO 供体配体的 μ-氧桥连二价钒(V)配合物与 DNA/BSA 的相互作用和体外细胞毒性。
J Inorg Biochem. 2022 Aug;233:111852. doi: 10.1016/j.jinorgbio.2022.111852. Epub 2022 May 10.
4
Dithiocarbazate based oxidomethoxidovanadium(V) and mixed-ligand oxidovanadium(IV) complexes: Study of solution behavior, DNA binding, and anticancer activity.基于二硫代卡巴腙的氧化亚甲基氧钒(V)和混合配体氧钒(IV)配合物:溶液行为、DNA 结合和抗癌活性研究。
J Inorg Biochem. 2022 Aug;233:111844. doi: 10.1016/j.jinorgbio.2022.111844. Epub 2022 Apr 26.
5
Binding of V O , V OL, V OL and V O L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications.V O 、V OL 、V OL 和 V O L 部分与蛋白质的结合:X 射线/理论特征及生物学意义。
Chemistry. 2022 Jul 15;28(40):e202200105. doi: 10.1002/chem.202200105. Epub 2022 Jun 8.
6
Dithiocarbazate-Fe, -Co, -Ni, and -Zn Complexes: Design, Synthesis, Structure, and Anticancer Evaluation.二硫代卡巴腙-铁、-钴、-镍和-锌配合物:设计、合成、结构及抗癌评估
J Med Chem. 2022 May 12;65(9):6677-6689. doi: 10.1021/acs.jmedchem.1c02186. Epub 2022 Apr 21.
7
Water-Soluble Dioxidovanadium(V) Complexes of Aroylhydrazones: DNA/BSA Interactions, Hydrophobicity, and Cell-Selective Anticancer Potential.水可溶性二氧代钒(V)配合物的芳酰腙:DNA/BSA 相互作用、疏水性和细胞选择性抗癌潜力。
Inorg Chem. 2021 Oct 18;60(20):15291-15309. doi: 10.1021/acs.inorgchem.1c01899. Epub 2021 Oct 1.
8
Protein binding and cytotoxic activities of monomeric and dimeric oxido-vanadium(V) salan complexes: Exploring the solution behavior of monoalkoxido-bound oxido-vanadium(V) complex.单体和二聚氧代钒(V)沙兰配合物的蛋白结合和细胞毒性活性:探索单烷氧基结合的氧代钒(V)配合物的溶液行为。
J Inorg Biochem. 2021 Nov;224:111582. doi: 10.1016/j.jinorgbio.2021.111582. Epub 2021 Aug 17.
9
Dithiocarbazate-Copper Complexes for Bioimaging and Treatment of Pancreatic Cancer.二硫代氨基甲酸盐-铜配合物用于胰腺癌的生物成像和治疗。
J Med Chem. 2021 May 13;64(9):5485-5499. doi: 10.1021/acs.jmedchem.0c01936. Epub 2021 Apr 16.
10
Are vanadium complexes druggable against the main protease M of SARS-CoV-2? - A computational approach.钒配合物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的主要蛋白酶M是否具有成药潜力?——一种计算方法。
Inorganica Chim Acta. 2021 May 1;519:120287. doi: 10.1016/j.ica.2021.120287. Epub 2021 Feb 11.